However, multiple group comparison analyses did not reveal any significant differences in expression levels of MALAT1, H19 or FENDRR between different histological subtypes, GIST risk grades or KIT/PDGFRA mutational status (S4 and S5 Tables). The gene discussed is PDGFRA; the disease is gastrointestinal stromal tumor.